Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
70.7M
-
Shares change
-
+2.77M
-
Total reported value, excl. options
-
$747M
-
Value change
-
+$27.8M
-
Put/Call ratio
-
0.11
-
Number of buys
-
64
-
Number of sells
-
-67
-
Price
-
$10.56
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q2 2022
172 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q2 2022.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 70.7M shares
of 101M outstanding shares and own 69.99% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (13.2M shares), VANGUARD GROUP INC (9.67M shares), BlackRock Inc. (6.91M shares), Point72 Asset Management, L.P. (5.07M shares), STATE STREET CORP (4.61M shares), ARMISTICE CAPITAL, LLC (4.09M shares), FIRST TRUST ADVISORS LP (4.08M shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1.57M shares), GEODE CAPITAL MANAGEMENT, LLC (1.56M shares), and JACOBS LEVY EQUITY MANAGEMENT, INC (1.46M shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.